China's Vidarabine Monophosphate Market from 2012 to 2016

China's Vidarabine Monophosphate Market from 2012 to 2016

China's Vidarabine Monophosphate Market

With the rapid spread of viral hepatitis and other diseases in the world, the demand for therapeutic drug has increased sharply in recent years, which promotes the rapid development of vidarabine monophosphate market. The data statistics of Chinese Hospital Association shows that the drug cost of vidarabine monophosphate for injection has reached CNY 67.6 million in 690 large hospitals of China’s 84 cities. Plus a small number of other urban hospitals which are not counted, the sales amount of vidarabine monophosphate for injection reached about CNY75 million in China in 2011.

The overall production capacity of China’s vidarabine monophosphate was estimated to be about CNY 100 million in 2011. And about CNY 30 million was used in export which mainly faced for India, Germany and other countries.

Key highlights of the report: 

• Market status of Vidarabine Monophosphate for Injection in Chinese Hospitals
• Production Capacity and Main Distribution Area 
• Demand Characteristics and Main Distribution Area 
• Development Trend of Product Technology
• Product Price Trend and Influence Factor
• Project Investment Suggestion and Risk Alarm